Vaniqa Related Clinical Trials
Trial of Eflornithine Plus Sulindac in Patients With Familial Adenomatous Polyposis (FAP) [Recruiting]
A Trial of Low Dose Sulindac Combined With Eflornithine in Patients With Familial Adenomatous Polyposis (FAP) [Withdrawn]
Acetylsalicylic Acid and Eflornithine in Treating Patients at High Risk for Colorectal Cancer [Recruiting]
Eflornithine To Prevent Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia [Completed]
Eflornithine and Sulindac in Preventing Colorectal Cancer in Patients With Colon Polyps [Completed]
Celecoxib With or Without Eflornithine in Preventing Colorectal Cancer in Patients With Familial Adenomatous Polyposis [Terminated]
Eflornithine and/or Diclofenac in Treating Patients With Sun-Damaged Skin [Completed]
Neoadjuvant Eflornithine and Bicalutamide Compared With Eflornithine Alone, Bicalutamide Alone, and No Neoadjuvant Therapy in Treating Patients With Localized Prostate Cancer Undergoing Brachytherapy or Radical Prostatectomy [Completed]
Urinary Biomarker Study With Sulindac and Difluoromethylornithine [Withdrawn]
Clinical Study to Assess the Tolerability, Feasibility and Effectiveness of Nifurtimox and Eflornithine (NECT) for the Treatment of Trypanosoma Brucei Gambiense Human African Trypanosomiasis (HAT) in the Meningo-encephalitic Phase [Completed]
Eflornithine + Nifurtimox Late-Stage Human African Trypanosomiasis (HAT)in West Nile, Uganda [Terminated]
Pivotal Study of Fexinidazole for Human African Trypanosomiasis in Stage 2 [Recruiting]
Eflornithine to Prevent Cancer in Patients With Barrett's Esophagus [Completed]
Eflornithine in Treating Patients At High Risk of Developing Prostate Cancer [Active, not recruiting]
Eflornithine With or Without Triamcinolone in Preventing Nonmelanoma Skin Cancer in Patients With Actinic Keratosis [Completed]
Evaluation of Eflornithine on Facial and Forearm Skin [Completed]
Efficacy - Safety of Eflornithine-Nifurtimox Combination Versus Eflornithine to Treat Human African Trypanosomiasis [Completed]
Effect of 15% Eflornithine Hydrochloride Cream on African-American Males With Pseudofolliculitis Barbae [Completed]
Treatment With Topical Eflornithin After Laser Treatment in Women With Facial Hirsutism [Completed]
Preventative Trial of Difluoromethylornithine (DFMO) in High Risk Patients With Neuroblastoma That is in Remission [Recruiting]
Difluoromethylornithine (DFMO) Chemoprevention of Skin Cancer in Organ Transplant Recipients [Completed]
Randomized Clinical Trial of Three Drug Combinations for Late-Stage Gambiense Human African Trypanosomiasis [Terminated]
Eflornithine in Treating Patients With Bladder Cancer [Completed]
Eflornithine to Prevent Skin Cancer in Patients With Previously Treated Early Stage Skin Cancer [Completed]
Eflornithine Plus Sulindac in Preventing Colorectal Cancer in Patients With Benign Colorectal Polyps [Completed]
N2012-01: Phase 1 Study of Difluoromethylornithine (DFMO) and Celecoxib With Cyclophosphamide/Topotecan [Recruiting]
DFMO in Children With Type 1 Diabetes [Recruiting]
Preventative Trial of DFMO in Patients With High Risk Neuroblastoma in Remission [Active, not recruiting]
Safety Study for Refractory or Relapsed Neuroblastoma With DFMO Alone and in Combination With Etoposide [Active, not recruiting]
Study of DFMO in Combination With Bortezomib for Relapsed or Refractory Neuroblastoma [Recruiting]
|